<DOC>
	<DOCNO>NCT01449175</DOCNO>
	<brief_summary>The purpose study provide post market clinical follow-up ( PMCF ) obtain long term safety efficacy information AeriSeal System treatment patient advance emphysema .</brief_summary>
	<brief_title>A Registry Study AeriSealÂ® System Lung Volume Reduction Patients With Advanced Emphysema</brief_title>
	<detailed_description>The purpose study provide post market clinical follow-up ( PMCF ) obtain long term safety efficacy information AeriSeal System treatment patient advance homogeneous heterogeneous emphysema .</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>Confirmation completion Aeris ' post market followup Continuation Study , 03C10001PLV .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>AeriSeal</keyword>
	<keyword>treatment</keyword>
	<keyword>device</keyword>
	<keyword>breathing</keyword>
	<keyword>COPD</keyword>
	<keyword>emphysema</keyword>
	<keyword>polymeric lung volume reduction ( PLVR )</keyword>
	<keyword>biologic lung volume reduction ( BLVR )</keyword>
	<keyword>heterogeneous</keyword>
	<keyword>homogeneous</keyword>
	<keyword>Respiratory Tract Diseases</keyword>
	<keyword>Lung Diseases</keyword>
	<keyword>Pulmonary Disease , Chronic Obstructive</keyword>
</DOC>